How Is The Testing Of Babies In Italy For Coeliac Disease And Type 1 Diabetes Going?
I asked Google AI the question in the title of this post and received this reply.
Testing babies and children for coeliac disease and type 1 diabetes in Italy is progressing successfully, rooted in groundbreaking legislation. Italy is the first country to pass a national law (Law 130/2023) mandating mass screening for these conditions in children aged 1 to 17.
The pilot project, known as the D1Ce Screen, was rolled out in four key regions: Lombardia, Sardegna, Marche, and Campania. Testing is typically conducted at ages 2, 6, and 10.
Here is how the rollout is progressing based on interim data and reports:
Pilot Study Success: The screening involves a simple capillary (finger-prick) blood draw administered by primary care pediatricians. Participation in the initial phase was high, with over 75% of pediatricians and thousands of children successfully screened.
Higher-Than-Average Positivity Rates: Preliminary data revealed that approximately 2.8% to 2.9% of children tested positive for coeliac-specific antibodies—more than double the global average of 1% to 1.4%. Additionally, around 0.8% of children displayed markers for type 1 diabetes.
Early Detection: The pilot has proven highly effective at identifying asymptomatic or “silent” cases of both conditions early, which is vital for preventing acute complications like Diabetic Ketoacidosis (DKA) and avoiding the long-term impacts of undiagnosed coeliac disease.
High Public Acceptance: Surveys from the pilot regions indicate that more than 90% of parents are highly willing to have their children screened, though general public awareness of the national program is still being scaled up.
Following these successful pilot rollouts, the government continues to expand the screening program to ensure full, nationwide coverage to protect at-risk children before severe symptoms develop.
No comments yet.
The Anonymous Widower 
Leave a comment